Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2014, Vol. 34 Issue (4): 9-15    DOI: 10.13523/j.cb.20140402
    
The Effects of Glutamine and Asparagine on CHO Cell Growth, Metabolism and Antibody Production
ZHANG Wei-yan, LIU Ya-ya, LIU Xu-ping, FAN Li, TAN Wen-song
State Key Lab of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China
Download: HTML   PDF(909KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

The effects of glutamine and asparagine on CHO cell growth, metabolism and antibody expression in batch culture with cells being centrifuged were investigated. It was found that glutamine can't be replaced by asparagine simply, CHO-dhfr cells can't grow normally in adding separately experiments. When glutamine and asparagine concentration reached 4mmol/L meanwhile can support normal growth of CHO cells. As the total amount of glutamine and asparagine increased (0 to 24mmol/L), ammonia concentration increased linearly, however, ammonia production had no relationship with proportion of glutamine and asparagine. Furthermore, improving the asparagine and glutamine proportion moderately not only can increase the antibody production but also decrease the lactate production. In brief, the foundation of supplement of glutamine and asparagine in development and optimization of mediums and efficient fed-batch process for antibody production was established.



Key wordsGlutamine      Asparagine      Proportion      Total amount      Antibody      Ammonia      Lactate     
Received: 10 January 2014      Published: 25 April 2014
ZTFLH:  Q256  
Cite this article:

ZHANG Wei-yan, LIU Ya-ya, LIU Xu-ping, FAN Li, TAN Wen-song. The Effects of Glutamine and Asparagine on CHO Cell Growth, Metabolism and Antibody Production. China Biotechnology, 2014, 34(4): 9-15.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.20140402     OR     https://manu60.magtech.com.cn/biotech/Y2014/V34/I4/9


[1] Drews M,Doverskog M, Ohman L, et al.Pathways of glutamine metabolism in Spodoptera frugiperda(Sf9) insect cells: evidence for the presence of the nitrogen assimilation system, and a metabolic switch by1H/15N NMR. J Biotechnol,2000, 78:23-37.

[2] 张淑香, 李东晓, 朱明龙, 等. 谷氨酰胺限制对杂交瘤细胞生长, 代谢和单抗生产的影响. 高校化学工程学报, 2008, 22(1): 77-82. Zhang S X, Li D X, Zhu M L, et al. Effect of glutamine limitation on growth, metabolism and mAb production of hybridoma cells. Journal of Chemical Engineering, 2008, 22(1): 77-82.

[3] Huang H, Yu Y, Yi X, et al., Nitrogen metabolism of asparagine and glutamate in Vero cells studied by 1H/ 15N NMR spectroscopy. Appl Microbiol Biotechnol, 2007. 77(2):427-436.

[4] Xing Z, Kenty B, Koyrakh I, et al. Optimizing amino acid composition of CHO cell culture media for a fusion protein production. Process Biochemistry, 2011, 46(7): 1423-1429.

[5] Lu F, Toh PC, Burnett I, et al. Automated dynamic fed-batch process and media optimization for high productivity cell culture process development. Biotechnology and Bioengineering, 2013, 110(1): 191-205.

[6] Ozturk S S, Riley M R, Palsson B O. Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production. Biotechnology and Bioengineering, 1992, 39(4): 418-431.

[7] Newland M, Kamal M N, Greenfield PF, et al. Ammonia inhibition of hybridomas propagated in batch, fed-batch, and continuous culture. Biotechnology and Bioengineering, 1994, 43(5): 434-438.

[8] Yang M, Butler M. Effects of ammonia on CHO cell growth, erythropoietin production, and glycosylation. Biotechnology and Bioengineering, 2000, 68(4): 370-380.

[9] Hyde R, Taylor P, Hundal H. Amino acid transporters: roles in amino acid sensing and signalling in animal cells. Biochem J, 2003, 373: 1-18.

[10] Utsunomiya-Tate N, Endou H, Kanai Y. Cloning and functional characterization of a system ASC-like Na+-dependent neutral amino acid transporter. Journal of Biological Chemistry, 1996, 271(25): 14883-14890.

[11] Kanai Y, Hediger M A. The glutamate and neutral amino acid transporter family: physiological and pharmacological implications. European Journal of Pharmacology, 2003, 479(1): 237-247.

[12] Cooney D A, Capizzi R L, Handschumacher R E. Evaluation of L-asparagine metabolism in animals and man. Cancer Research, 1970, 30(4): 929-935.

[13] Lea PJ, Robinson S A, Stewart G R. The enzymology and metabolism of glutamine, glutamate, and asparagine. The Biochemistry of Plants, 1990, 16: 121-159.

[14] Altamirano C, Paredes C, Illanes A, et al. Strategies for fed-batch cultivation of t-PA producing CHO cells: substitution of glucose and glutamine and rational design of culture medium. Journal of Biotechnology, 2004, 110(2): 171-179.

[15] Altamirano C, Paredes C, Cairo J J, et al. Improvement of CHO cell culture medium formulation: simultaneous substitution of glucose and glutamine. Biotechnology Progress, 2000, 16(1): 69-75.

[16] McDermott R H, Butler M. Uptake of glutamate, not glutamine synthetase, regulates adaptation of mammalian cells to glutamine-free medium. Journal of Cell Science, 1993, 104(1): 51-58.

[17] Altamirano C, Paredes C, Cairo J J, et al. Improvement of CHO cell culture medium formulation: simultaneous substitution of glucose and glutamine. Biotechnology Progress, 2000, 16(1): 69-75.

[18] Kim D Y, Chaudhry M A, Kennard M L, et al. Fed-batch CHO cell t-PA production and feed glutamine replacement to reduce ammonia production. Biotechnology Progress, 2013, 29(1): 165-175.

[19] Chen F, Fan L, Wang J, et al. Insight into the roles of hypoxanthine and thydimine on cultivating antibody-producing CHO cells: cell growth, antibody production and long-term stability. Applied Microbiology and Biotechnology, 2012, 93(1): 169-178.

[20] Dean J, Reddy P. Metabolic analysis of antibody producing CHO cells in fed-batch production. Biotechnology and Bioengineering, 2013, 110(6): 1735-1747.

[1] CHEN Xiu-yue,ZHOU Wen-feng,HE Qing,SU Bing,ZOU Ya-wen. Preparation, Purification and Identification of Bacteriophage Qβ Virus-like Particles[J]. China Biotechnology, 2021, 41(7): 42-49.
[2] CHEN Wen-jie,MIAO Xian-feng. Domestic Research and Development Status of Antibody-drug Conjugates and Strategic Layout of Key Enterprises[J]. China Biotechnology, 2021, 41(6): 105-110.
[3] XU Ye-chun,LIU Hong,LI Jian-feng,SHEN Jing-shan,JIANG Hua-liang. Recent Progress in Drug Development against COVID-19[J]. China Biotechnology, 2021, 41(6): 111-118.
[4] YUAN Bo,WANG Jie-wen,KANG Guang-bo,HUANG He. Research Progress and Application of Bispecific Nanobody[J]. China Biotechnology, 2021, 41(2/3): 78-88.
[5] MAO Kai-yun,LI Rong,LI Dan-dan,ZHAO Ruo-chun,FAN Yue-lei,JIANG Hong-bo. Analysis of the Current Status of Global Bispecific Antibody Development[J]. China Biotechnology, 2021, 41(11): 110-118.
[6] ZHAO Yan-shu,ZHANG Jin-hua,SONG Hao. Advances in Production of Monoclonal Antibody and Antibody Fragments in Engineered Prokaryotes and Yeast[J]. China Biotechnology, 2020, 40(8): 74-83.
[7] YANG Xiao-ying,LI Meng,ZHAO Wei,TANG Min,ZHANG Zhi-qian. Preparation and Preliminary Characterization of Anti-α2δ1/CD3 Bispecific Antibody[J]. China Biotechnology, 2020, 40(7): 9-14.
[8] WU Rui-jun,LI Zhi-fei,ZHANG Xin,PU Run,AO Yi,SUN Yan-rong. Development and Prospect of Antibody Drugs for SARS-CoV-2[J]. China Biotechnology, 2020, 40(5): 1-6.
[9] YANG Li,SHI Xiao-yu,LI Wen-lei,LI Jian,XU Han-mei. Optimization of Electroporation Conditions in Construction of Phage Display Antibody Library[J]. China Biotechnology, 2020, 40(4): 42-48.
[10] LI Tong-tong,SONG Cai-ling,YANG Kai-yue,WANG Wen-jing,CHEN Hui-yu,LIU Ming. Preparation and Neutralization Activity of Anti-Canine Parvovirus VP2 Protein Single-chain Antibody[J]. China Biotechnology, 2020, 40(4): 10-16.
[11] WANG Meng,SONG Hui-ru,CHENG Yu-jie,WANG Yi,YANG Bo,HU Zheng. Accurate Detection of Streptococcus pneumoniae by Using Ribosomal Protein L7 / L12 as Molecular Marker[J]. China Biotechnology, 2020, 40(4): 34-41.
[12] CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein[J]. China Biotechnology, 2020, 40(3): 31-37.
[13] LI Dong-qiao,LV Lu-cheng,YANG Yan-ping. The Research Status and Development Trend of Global Human Coronavirus Antibody Field[J]. China Biotechnology, 2020, 40(1-2): 65-70.
[14] KONG Jian-tao,ZHUANG Ying-ping,GUO Mei-jin. Enhancement of Anti-CD20 Monoclonal Antibody Expression by CHO based on DOE and Amino Acid Supplemental Strategy[J]. China Biotechnology, 2020, 40(12): 41-48.
[15] HE Meng,ZHANG Guo-lin,LI Yan,HAN Xue-bo,LIU Hong-peng,LI Xin,QIAN Ling-ling,LIU Kun-mei,GUO Le. Soluble Expression of Recombinant Antigen CagL from Helicobacter pylori Pathogenicity Island and Preparation and Analysis of Anti-CagA Polyclonal Antibody[J]. China Biotechnology, 2020, 40(11): 21-27.